Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    Plastics in Transition

    Technology insight report on plastic waste management

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventors Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Water-related technologies
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Technologies
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2024 activities
        • 2025 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Water-related technologies
      • CodeFest
        • Go back
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • Daily D questions
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • The PATLIB Knowledge Transfer to Africa initiative (KT2A)
          • KT2A core activities
          • Success story: Malawi University of Science and Technology and PATLIB Birmingham
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Technologies
        • Go back
        • Overview
        • Innovation against cancer
        • Assistive robotics
        • Space technologies
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
          • Go back
          • Overview
          • Publications
        • Research universities and public research organisations
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 2635/18 28-01-2022
Facebook X Linkedin Email

T 2635/18 28-01-2022

European Case Law Identifier
ECLI:EP:BA:2022:T263518.20220128
Date of decision
28 January 2022
Case number
T 2635/18
Petition for review of
-
Application number
12726921.5
IPC class
G02B 1/04
Language of proceedings
EN
Distribution
NO DISTRIBUTION (D)

Download and more information:

Decision in EN 416.86 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

MEDICAL DEVICES HAVING HOMOGENEOUS CHARGE DENSITY AND METHODS FOR MAKING SAME

Applicant name
Johnson & Johnson Vision Care, Inc.
Opponent name
Novartis AG
Board
3.3.03
Headnote
-
Relevant legal provisions
European Patent Convention Art 84
European Patent Convention Art 123(2)
European Patent Convention Art 54
European Patent Convention Art 56
Keywords

Novelty - main request (no)

Amendments - added subject-matter (no)

Claims - clarity

Claims - auxiliary request (yes)

Inventive step - auxiliary request

Inventive step - non-obvious alternative

Catchword
-
Cited decisions
T 1023/02
Citing decisions
T 0358/19
T 0372/19
T 1260/19
T 1442/19

I. The appeals of the patent proprietor and of the opponent lie from the interlocutory decision of the opposition division posted on 17 August 2018 concerning maintenance of European Patent number 2 705 390 in amended form on the basis of the claims of auxiliary request 1 filed during oral proceedings on 22 June 2018 and an adapted description. The contested decision was also based on a main request filed during the same oral proceedings.

II. Claim 11 of the main request corresponded to granted claim 14 and read as follows:

"11. A silicone hydrogel formed from a reactive mixture comprising

major polymerisable components comprising at least one reactive silicone-containing component, at least one reactive ionic monomer, optional reactive hydrophilic components and crosslinker; and

minor polymerisable components selected from the group consisting of visibility tint and dyes, UV absorbers, photochromic compounds, pharmaceutical compounds, nutriceutical compounds, and mixtures thereof;

wherein said major polymerisable components comprise a single reactive functionality,

wherein said single reactive functionality is selected from the group consisting of acrylate, methacrylate, acrylamide, and methacrylamide."

Claim 11 of auxiliary request 1 read as follows:

"11. A silicone hydrogel formed from a reactive mixture comprising

major polymerisable components comprising at least one reactive silicone-containing component, at least one reactive ionic monomer, [deleted: optional] reactive hydrophilic components and crosslinker; and

minor polymerisable components selected from the group consisting of visibility tint and dyes, UV absorbers, photochromic compounds, pharmaceutical compounds, nutriceutical compounds, and mixtures thereof;

wherein said major polymerisable components comprise a single reactive functionality,

wherein said single reactive functionality is selected from the group consisting of [deleted: acrylate, methacrylate, ]acrylamide, and methacrylamide." (deletions in comparison to granted claim 14 in [deleted: strikethrough])

The remaining claims of the main request and auxiliary request 1 are not relevant to the present decision. It is only pointed out that the main request and auxiliary request 1 included claims 1-10 which covered contact lenses.

III. The following document was inter alia cited in the contested decision:

HBP5: WO 2010/039653 A1

IV. In that decision the opposition division held, among others, that:

- The main request complied with the requirements of Rule 80 and Articles 83, 84 and 123(2) EPC. However the subject matter of claim 11 of the main request was not novel in view of document HBP5.

- Auxiliary request 1 was admitted into the opposition proceedings. It was held that said request complied with the requirements of Articles 84, 83 and 54 and Rule 80 EPC. The closest prior art for the subject-matter of claim 11 was HBP5. Starting from this document, the problem to be solved was the provision of an alternative silicone hydrogel with improved balance of lysozyme/PQ1 uptake. The solution to that problem was neither disclosed nor hinted at in the cited prior art. Therefore the subject-matter of claim 11 of auxiliary request 1 involved an inventive step.

V. With the statement setting out the grounds of appeal the patent proprietor (appellant 1) filed a main request (corresponding to the main request on which the contested decision was based) and auxiliary requests 1 and 2.

With the rejoinder to the statement of grounds of the opposing party appellant 1 additionally filed auxiliary requests 1.i to 1.iv, 2.i to 2.iv, 3, 3.i to 3.iv, 4, 4.i to 4.iv, 5, 5.i to 5.iv, 6, 6.i to 6.iv, 7, 7.i to 7.iv, 8, 8.i to 8.iv, 9, 9.i to 9.iv, 10, 10.i, 11, 11.i, 12, 12.i, 13 and 14.

Claim 1 of auxiliary request 1.iv only differs from granted claim 14 in that the word "optional" is deleted (see point II. of the present decision).

Claim 1 of auxiliary request 2.iv is identical to claim 11 of auxiliary request 1 dealt with by the opposition division.

Claim 1 of auxiliary request 13 is identical to granted claim 14.

Furthermore in auxiliary requests 1.iv, 2.iv and 13 the claims directed to contact lenses (granted claims 1-13) were deleted.

The remaining requests are not relevant to the present decision.

VI. With its statement setting out the grounds of appeal the opponent (appellant 2) requested that the decision under appeal be set aside and that the patent be revoked.

VII. With letter of 7 December 2021 appellant 1 withdrew

the main request and auxiliary requests 1, 1.i to 1.iii, 2, 2.i to 2.iii, 3, 3.i to 3.iii, 4, 4.i to 4.iii, 5, 5.i to 5.iii, 6, 6.i to 6.iii, 7, 7.i to 7.iii, 8, 8.i to 8.iii, 9, 9.i to 9. iii, 10, 10.i, 11, 11.i, 12, 12.i, and 14

and requested maintenance of the opposed patent on the basis of

auxiliary requests 13 or 1.iv to 9.iv (in the given order of preference).

VIII. Oral proceedings were held before the Board on 28 January 2022 by video conference.

IX. Appellant 1's arguments, insofar as relevant to the decision, may be summarised as follows:

(a) Auxiliary request 13

(i) Novelty over HBP5

Claim 1 of auxiliary request 13 covered a hydrogel formed from a reactive mixture comprising major silicone components wherein said major components had the same reactive functionality (feature "single reactive functionality" of claim 1).

While the preamble of the claim referred to "a reactive mixture comprising ... ", the term "comprising" did not mean that major polymerisable components could be present with reactive functionalities different from the ones of the other major polymerisable components because this would be inconsistent with the requirement for a single reactive functionality. Instead, the term "comprising" meant that other components (e.g. an initiator or a diluent) could be present in the mixture, as long as the other requirements of claim 1 were met. Therefore claim 1 did not include a composition wherein all the major components (i.e. the reactive silicone-containing components, the reactive ionic monomers, the reactive hydrophilic components and the crosslinkers) did not have the same functionality.

This interpretation of the term "comprising" was in line with decision T 1023/02 in which the Board held that

"a claim using "comprising" language should generally not be construed as covering subject-matter which included further steps of a nature that would manifestly counteract the specified technical purpose of the step(s) recited in the claim."

Furthermore, although claim 1 was clear from its wording alone, all inventive examples of the opposed patent were consistent with this interpretation while, in comparative examples 7 and 8, the reactive mixture included major polymerisable components with different reactive functionalities.

With regard to HPB5, this document did not disclose a composition wherein all major polymerisable components had the same reactive functionality as required by present claim 1. For instance the reactive mixture in table 4 of HBP5 comprised N,N-dimethylacrylamide (DMA) which

was a reactive hydrophilic monomer and therefore a major polymerisable component and

had a reactive functionality (acrylamide) different from the reactive functionality of the other major polymerisable components (methacrylate).

Therefore the subject-matter of claim 1 was novel over HBP5.

(b) Auxiliary request 1.iv

(i) Novelty over HBP5

The above arguments equally applied to claim 1 of auxiliary request 1.iv.

(c) Auxiliary request 2.iv

(i) Article 123(2) EPC

Claim 1 of auxiliary request 2.iv was derived from claim 36 as filed wherein :

i) the group "vinyl" was deleted from a list of 3 possible reactive functionalities ("acrylamide, methacrylamide and vinyl") and

ii) the term "optional" was deleted.

Contrary to the view of appellant 2, the choice of a dependent claim (here claim 36) was not a selection. Likewise the deletion of the term "optional" and "vinyl" were not to be considered as selections but as limitation to a preferred embodiment of the invention. Besides the examples of the application as filed were clear pointers to the subject-matter of claim 1 of auxiliary request 2.iv.

Therefore the subject matter of present claim 1 complied with the requirements of Article 123(2) EPC.

(ii) Article 84 EPC

The deletion of "optional" did not lead to a lack of clarity. Moreover, the issues alleged by appellant 2 were present in granted claim 14, and "optional" features were assessed for clarity during examination. Therefore, the deletion of "optional" could not have introduced a lack of clarity into the claim, and this amendment could not be examined under Article 84 EPC, following G 3/14.

(iii) Inventive step

HBP5 was the closest prior art for the subject-matter of claim 1. Claim 1 differed from this document in that the reactive composition comprised major polymerisable components (including at least one reactive silicone-containing component, at least one reactive ionic monomer, reactive hydrophilic components and a crosslinker) with the same reactive functionality selected from acrylamide and methacrylamide.

Since the major reactive components had the same reactive functionality, it was credible that the structure of the polymer obtained therefrom was that of a random copolymer with an improved distribution of charges along the polymer chain. Furthermore, based on the experimental evidence provided in the opposed patent, it was shown that the distinguishing features of present claim 1 lead to a reduced PQ1 (polyquaternium disinfecting compound) uptake compared to copolymers with an irregular distribution of charges. Therefore the objective problem to be solved was to provide a copolymer with an improved distribution of charges.

As none of the cited documents suggested to use monomers with the same reactive functionalities, the solution to the above problem was not obvious.

Furthermore, should the problem to be solved be formulated as the provision of an alternative reactive composition for the manufacture of contact lenses (second problem), the following was argued:

HBP5 did not suggest to replace all major reactive components by acrylamide or methacrylamide based monomers. In fact HBP5 did not even disclose a (meth)acrylamide-base crosslinker or a contact lens wherein the majority of the reactive components were (meth)acrylamides. The solution to the second problem was therefore also not obvious for a person skilled in the art.

X. Appellant 2's arguments, insofar as relevant to the decision, may be summarised as follows:

(a) Auxiliary request 13

(i) Novelty over HBP5

Table 4 of HBP5 disclosed a reactive composition comprising major reactive components with the same reactive functionality (methacrylate). Although DMA (corresponding to a hydrophilic acrylamide monomer) was also present, this was not excluded by present claim 1 due to the wording "comprising".

Contrary to appellant 1's view, "comprising" should be given its normal meaning in patent claims. Furthermore, the cited decision T 1023/02 did not apply to the present case since it related to a method claim wherein further possible steps would counteract the purpose of the step(s) recited in the claim. However no such contradiction was present in present claim 1.

Therefore the subject-matter of claim 1 of auxiliary request 13 was not novel over HBP5.

(b) Auxiliary request 1.iv

(i) Novelty over HBP5

The above arguments equally applied to claim 1 of auxiliary request 1.iv.

(c) Auxiliary request 2.iv

(i) Article 123(2) EPC

The subject-matter of claim 1 relied on multiple selections. A first selection was the choice of a specific dependent claim (such as claim 36 as filed) in a list of alternative embodiments of the originally filed application. A further selection was the choice of specific reactive functionalities, which were restricted to acrylamide and methacrylamide. These specific functionalities were combined with selected components, in particular reactive hydrophilic components and a crosslinker, which were no longer optional.

The specific combination of features of present claim 1 found therefore no basis in the application as filed, contrary to Article 123(2) EPC. The same conclusion applied to dependent claims 2 and 3.

(ii) Article 84 EPC

Claim 1 of auxiliary request 2.iv corresponded to granted claim 14 in which the word "optional" was deleted. This amendment led to a lack of clarity, since it was unclear:

whether the major polymerisable component comprised at least two hydrophilic components or only one and

whether the hydrophilic components and the crosslinker were necessarily different or not.

(iii) Inventive step

HBP5 was the closest prior art for the subject-matter of claim 1. Claim 1 differed from the disclosure of HBP5 in that the reactive mixture comprised major polymerisable components with the same reactive functionality selected from acrylamide and methacrylamide.

It was neither shown nor made credible that the choice of (meth)acrylamide-based monomers led to an improvement of the charge distribution in the polymer chain or to a reduction of the PQ1 uptake in the contact lenses. The problem to be solved was therefore the provision of an alternative to the silicone hydrogel of HBP5.

HPB5 disclosed that the major polymerisable components could have an acrylamide or methacrylamide functionality. It was therefore an obvious option for a person skilled in the art to replace the reactive functionalities of the major polymerisable components of HBP5 by acrylamide or methacrylamide groups.

Thus, the subject-matter of claim 1 of auxiliary request 2.iv lacked an inventive step over HBP5 alone.

XI. Appellant 1 requested that the decision under appeal be set aside and the patent be maintained on the basis of one of auxiliary requests 13 or 1.iv to 9.iv filed with the rejoinder to the statement of grounds of appeal.

XII. Appellant 2 requested that the decision under appeal be set aside and that the patent be revoked.

1. Auxiliary request 13

1.1 Novelty

1.1.1 Interpretation of claim 1

Claim 1 of auxiliary request 13 covers a silicone hydrogel formed from a reactive mixture comprising:

"major polymerisable components" ...

"wherein said major polymerisable components comprise a single reactive functionality,

wherein said single reactive functionality is selected from the group consisting of acrylate, methacrylate, acrylamide, and methacrylamide." (emphasis added by the Board)

Appellant 1 considers that the requirement that the major polymerisable components comprise the same reactive functionality (in short: functionality A), limits the scope of claim 1 in the sense that the reactive mixture may not comprise any further component falling under the classes of components listed for the major component having a different functionality B (B!=A).

The Board cannot follow this interpretation of claim 1 for the following reasons:

The narrow interpretation of "comprising" contradicts the meaning of this word in the generally established case law (see Case Law of the Boards of Appeal, 9th edition 2019, II.A.6.2). In the Board's view the use of the word "comprising" leaves no doubt that further components may be present in the reaction mixture as long as major polymerisable components and minor polymerisable components according to claim 1 are present.

Contrary to appellant 1's view the fact that the reactive mixture comprises major polymerisable components with the same reactive group A does not exclude the presence of further (major) polymerisable components with a different reactive group B. The Board cannot recognise any contradiction or incompatibility within claim 1, even if it may have the consequence that a comparative example might fall under the scope of claim 1.

Appellant 1 cited the decision T 1023/02 of 19 May 2006 according to which

"a claim using 'comprising' language should generally not be construed as covering subject-matter which included further steps of a nature that would manifestly counteract the specified technical purpose of the step(s) recited in the claim." (see point 12 of the Reasons)

While this interpretation of the word "comprising" may be valid in a method claim (as it is the case in T1023/02), present claim 1 is a product claim with no such manifest contradiction.

Consequently, the Board considers that the wording of claim 1 does not per se exclude silicone hydrogels formed from a reactive mixture comprising a major reactive component having a different reactive functionality B than the required major reactive components with the reactive functionality A (B!=A).

1.1.2 Document HBP5

In the contested decision (see point 2.6.2), the opposition division came to the conclusion that present claim 1 (corresponding to claim 11 of the main request as dealt with in the decision) was not novel over the silicone hydrogel obtained from the reactive mixture in table 4 of HBP5.

Appellant 1 did not contest that HPB5 disclosed a silicone hydrogel derived from a reactive mixture comprising the required polymerisable components of claim 1 (taken individually), and in particular major polymerisable components having the same methacrylate functionality. It was only argued that the reactive composition of HBP5 further comprised DMA (a hydrophilic monomer with a reactive acrylamide group that is different from the reactive methacrylate groups of the other major components) which would be excluded from the scope of claim 1.

However, as explained above (see point 1.1.1 of the present decision), the Board considers that the use of the word "comprising" in claim 1 implies that the presence of DMA with a reactive functionality different from the other main polymerisable components is not excluded from the scope of claim 1.

Therefore the Board does not see any reason to deviate from the findings of the opposition division with the consequence that claim 1 of auxiliary request 13 lacks novelty over HBP5.

2. Auxiliary request 1.iv

2.1 Novelty over HBP5

Both parties in appeal had no additional and separate arguments on novelty for claim 1 of auxiliary request 1.iv, thereby accepting that any conclusion reached for claim 1 of auxiliary request 13 equally applied to it. The Board has no reason to come to a different conclusion (see point 1.1.2 of the decision). Therefore claim 1 of auxiliary request 1.iv lacks novelty over HBP5.

3. Auxiliary request 2.iv

3.1 Article 123(2) EPC

3.1.1 According to appellant 2, claim 1 of auxiliary request 2.iv is based on the following selections:

1. selection of a dependent claim (such as claim 36) in the set of claims of the application as filed,

2. selection of specific reactive functionalities, which are now limited to acrylamide and methacrylamide and

3. selection of a reactive mixture comprising reactive hydrophilic components and crosslinker.

Furthermore there would be no direct and unambiguous basis for the combination of present claim 1 in the application as filed. The same would apply to dependent claims 2 and 3.

The Board cannot follow this objection for the following reasons:

Contrary to appellant 2's view, the choice of a specific dependent claim in the original set of claims is not considered to be a selection but an individualised (preferred) embodiment of the application as filed. Thus, no selection is necessary to assess whether original claim 36 may be seen as a basis for the subject-matter of present claim 1.

Original claim 36 further discloses that the reactive functionalities may be selected from the group consisting of "acrylamide, methacrylamide and vinyl" Consequently the choice of "acrylamide and methacrylamide" can be seen as the deletion of "vinyl" in a list of three reactive groups. According to the boards' consistent case law (see Case Law of the Boards of Appeal, 9th edition 2019, II.E.1.6.3), deleting an element from a list of alternative options does not result in singling out a particular element in the list and therefore does not constitute a selection.

Finally the choice of a reactive mixture comprising reactive "hydrophilic components and crosslinker" (through the deletion of the term "optional") corresponds merely to the limitation of present claim 1 to an optional embodiment which was originally present in original claim 36 with back reference to original claim 34. The Board does not consider that the choice of said optional embodiment can be seen as a selection of an element from a list of multiple options.

Consequently the subject-matter of present claim 1 is not the result of multiple selections and the Board considers that present claim 1 finds a clear and unambiguous basis in original claim 36.

With regard to dependent claims 2 and 3, the Board considers that said claims find a direct and unambiguous basis in original claims 40-42 and on page 12, lines 11-15 of the application as filed.

Therefore claims 1 to 3 of auxiliary request 2.iv fulfil the requirements of Article 123(2) EPC.

3.2 Clarity

According to appellant 2, claim 1 of auxiliary request 2.iv corresponds to granted claim 14 in which among others the word "optional" was deleted (see statement of grounds of appeal, paragraph 5.2). This amendment would lead to a lack of clarity, since it would be unclear

whether the major polymerisable component should comprise at least two hydrophilic components or only one and

whether the hydrophilic components and the crosslinker are necessarily different or not.

The Board cannot identify any lack of clarity resulting from the deletion of the word "optional" in claim 1. In view of the formulation of claim 1, there is no doubt that the use of the plural for the reactive hydrophilic components means that the polymerisable main component should contain at least two reactive hydrophilic components. As to the question whether the crosslinker may be also hydrophilic, the Board does not see any reason that would speak against it.

Therefore, the amendments in present claim 1 do not lead to a lack of clarity.

3.3 Inventive step

3.3.1 Closest prior art

The parties agreed that HBP5 represented the closest prior art for claim 1 of auxiliary request 2.iv.

The Board sees no reason to deviate from that view.

3.3.2 Distinguishing features

It was not disputed between the parties that claim 1 differed from HBP5 in that the reactive mixture comprised major polymerisable components with the same reactive functionality selected from acrylamide and methacrylamide.

The Board agrees with the technical differences identified by the parties.

3.3.3 Objective technical problem

According to appellant 1, it was made credible that the structure of a polymer obtained from monomers having the same reactive functionality was that of a random copolymer with an improved distribution of charges along the polymer chain. Therefore the objective problem to be solved was to provide a copolymer with an improved distribution of charges.

The Board cannot follow this assessment of a technical effect for the following reasons:

It is first pointed out that the examples provided in the opposed patent do not investigate the distribution of charges in the copolymer of the hydrogel. It has also not been shown that any improvement is obtained compared to HBP5 in which a hydrogel is obtained from a reactive mixture wherein the major reactive components are all methacrylates (see HBP5, page 31, table 4 with back reference to pages 25-26).

Nonetheless, the Board considers that the final purpose of the opposed patent should be taken into consideration for the definition of the objective technical problem. It has indeed been shown that the silicone hydrogels according to present claim 1 can be used as contact lenses (see opposed patent, table 3 and paragraph [0144]). The same applies to the silicone hydrogels of HBP5 (see page 2, summary of the invention).

Thus the problem to be solved should be formulated as to provide an alternative silicone hydrogel for use in contact lenses.

3.3.4 Obviousness

It remains to be assessed whether it is obvious for the skilled person wishing to provide an alternative to the silicone hydrogels of HBP5, to select a reactive mixture wherein the major polymerisable components (including a reactive silicone containing component (i), a reactive ionic monomer (ii), reactive hydrophilic components (iii) and a crosslinker (iv)) have all the same reactive functionality selected from acrylamide or methacrylamide.

According to appellant 2, HPB5 discloses that the reactive groups of the monomers used as building block of the hydrogel may be acrylamide or methacrylamide. Consequently, it would be obvious to replace the reactive groups of each of the monomers (i)-(iv) by said groups in order to provide an alternative to the hydrogel of HBP5.

It is not disputed that HBP5 discloses that the reactive functionality of the polymerisable components may be acrylamide or methacrylamide (see HBP5, page 4, penultimate paragraph). However in order to show a lack of inventive step it must be considered whether the skilled person:

would have been able on the basis of the teaching of HBP5 to replace the reactive group in each of the monomers (i)-(iv) and

would have made these modifications with the expectation to obtain a silicone hydrogel for use as a contact lens.

The reactive silicone containing component (i) and the crosslinker (iv) are considered first.

With regard to the silicone monomer (i), the only specific examples of polymerisable groups present in component (i) are (meth)acrylate, vinyl carbonate or vinyl carbamate (see HBP5, page 8, first and last paragraphs). Furthermore in the examples of HBP5, the silicone based monomers are all (meth)acrylates (see HBP5, pages 25-26, bridging paragraph). It is furthermore pointed out that HBP5 does not teach how to obtain a (meth)acrylamide based silicone component (i). Besides appellant 2 has not shown that the preparation of said component (i) would belong to common general knowledge. Already for that reason the Board considers that it would not be obvious for the skilled person to replace the reactive silicone components of HBP5 by a reactive silicone having acrylamide or methacrylamide groups in view of the sole disclosure cited by appellant 2 for lack of inventive step, namely the one of HBP5.

With regard to the crosslinker (iv), the general part of the description of HBP5 only mentions that a crosslinker may be used without further details (see HBP5, page 4, lines 3-5 and page 13, third full paragraph). The only specific examples of crosslinkers in HBP5 are ethyleneglycol dimethacrylate and tetraethyleneglycol dimethacrylate (see HBP5, pages 25-26, bridging paragraph). Thus HPB5 does not disclose any specific (meth)acrylamide based crosslinker (iv) let alone a crosslinker (iv) suitable for contact lenses. It is furthermore pointed out that also in this respect appellant 2 did not rely on any other document for the attack of lack of inventive step than HBP5.

Finally, the Board is not convinced that the skilled person would expect that any modification made within the ambit of HBP5 could lead to a material suitable as contact lenses. In the present case, the concrete examples of contact lenses are derived from reactive mixtures wherein all major reactive monomers are methacrylates (see HBP5, examples). To arrive at the subject-matter of present claim 1, the skilled person would have to replace five methacrylate monomers (comprising a reactive silicone containing component (i), a reactive ionic monomer (ii), at least two reactive hydrophilic components (iii) and a crosslinker (iv)) by corresponding (meth)acrylamides, which represents a complete change in the basic structure of the hydrogel. Thus albeit HBP5 discloses various embodiments such as the possible reactive groups and the possible structures of the silicone polymeric structure (see HBP5, page 4, penultimate paragraph and page 7, formula), the person skilled in the art would have no reason to assume on the basis of the teaching of HBP5 alone that a hydrogel as set out in present claim 1 may still lead to a hydrogel for use as a contact lens.

Consequently, the Board considers that it is not an obvious option for the skilled person wishing to provide an alternative to the hydrogel of HBP5, to select a reactive mixture wherein the major polymerisable components (i)-(iv) have the same reactive functionality selected from acrylamide and methacrylamide in view of HBP5 alone, and in particular to choose a reactive silicone containing component (i) and a crosslinker (iv) as set out in claim 1 as none of these components is hinted at in HBP5.

Therefore the subject-matter of claim 1 involves an inventive step over HBP5 alone.

3.4 As all of the objections of appellant 2 against auxiliary request 2.iv fail, the patent is to be maintained on the basis of the said request.

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the department of first instance with the order to maintain the patent in amended form on the basis of the claims of auxiliary request 2.iv filed with the rejoinder to the statement of grounds of appeal and after any necessary consequential amendment of the description.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility